Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ulcerative Colitis Chronic Moderate: early-phase trial registry
3 of 3 indexed Ulcerative Colitis Chronic Moderate trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Ulcerative Colitis Chronic Moderate: 3 US clinical trials tracked, 3 recruiting.
Ulcerative Colitis Chronic Moderate is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Rise Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition ulcerative-colitis-chronic-moderate
OPEN 3 | RECR 100% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Ulcerative Colitis Chronic Moderate lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ulcerative Colitis Chronic Moderate on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ulcerative Colitis Chronic Moderate is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Rise Therapeutics
NCT05666960
Study of Novel Therapeutics for Acute Remedy of Colitis
Brigham and Women's Hospital
NCT06420492
Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis
University of California, San Diego
NCT06311123
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Ulcerative Colitis Chronic Moderate records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ulcerative Colitis Chronic Moderate trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ulcerative Colitis Chronic Moderate page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Ulcerative Colitis Chronic Moderate trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Rise Therapeutics sponsors the most Ulcerative Colitis Chronic Moderate trials on record, review their full trial history before evaluating a specific study. See Rise Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ulcerative Colitis Chronic Moderate condition card totals 3 registered trials; most-linked intervention BRS201; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.